Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/-mouse model within six months

Molecular and Cellular Biochemistry

Volumn 215, Issue 1-2, 2000, Pages 123-128

  Liu, L ^a   Hu, H ^a   Ji, H ^a   Murdin, A D ^b   Pierce, G N ^a   Zhong, G ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Aventis Pasteur   (Canada)

Author keywords

Chlamydial exacerbation of atherosclerosis

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE EXACERBATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; SCORING SYSTEM;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL; DIET; FEMALE; INFLAMMATION; LIPOPROTEINS; LIPOPROTEINS, LDL; MICE; MICE, KNOCKOUT; RECEPTORS, LDL; TIME FACTORS;

ANIMALIA; CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 0034516874     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026531506202     Document Type: Article

References (41)

1. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
2. Chlamydia pneumoniae and cardiovascular disease
3. Chlamydia pneumoniae and cardiovascular disease
4. Chlamydia pneumoniae and atherosclerosis - An update
5. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?
6. Chlamydia pneumoniae and atherosclerosis: Links to the disease process
7. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications
8. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)
9. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
10. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
11. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques
12. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae
13. Induction of macrophage foam cell formation by Chlamydia pneumoniae
14. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide
15. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
16. Rabbit model for Chlamydia pneumoniae infection
17. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
18. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
19. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis
20. Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis
21. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice
22. Lymphocyte populations in atherosclerotic lesions of apoE-/- and LDL receptor -/- mice. Decreasing density with disease progression
23. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation
24. Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis
25. Mouse models of Chlamydia pneumoniae infection and atherosclerosis
26. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice
27. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression
28. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice
29. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
30. Requirement for CD154 in the progression of atherosclerosis
31. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
32. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
33. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
34. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
35. Atherosclerosis is an inflammatory disease
36. Cell biology of atherosclerosis
37. P-selectin or Intercellular Adhesion Molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice
38. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells
39. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis
40. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
41. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells